Report Categories
View AllRecent Articles
View All
FTC Solar FTCI posts 110 percent YoY Q4 2025 revenue growth shares rise 28 percent on earnings beat
Does Immunic IMUX stock reflect fair pricing Immunic delivers 271 EPS beat with no Q4 revenue
FMFC Kandal M lays out multiyear digital payment penetration targets in its latest quarterly update
What affects Integra ITRG stock price 112 20260420
Appreciate CEO Highlights Five US Stocks for ShortTerm Focus as AI Spending Surges
EU Negotiators Reach Provisional Deal on Safeguard Clauses for EUUS Trade Agreement
La Ligas Indian Expansion Betting Big on Football in a CricketDominated Market
World Leaders Await TrumpXi Summit Outcome Amid Global Trade Uncertainty
Jamie Dimon Delivers Cautious Message to JPMorgan Bankers on Industry Headwinds
Puig Shares Decline as Este Lauder Merger Talks End European Markets Edge Higher Amid Geopolitical and Economic Focus
Tencent Unveils New AI Tools and Enterprise Solutions at Inaugural Tencent Cloud Day Hong Kong
Meta Stock Declines After Quarterly Results Cite Iran Internet Disruptions Impacting User Numbers
BlockCon Punta Cana Where Web3 iGaming and Finance Intersect at Global Business Retreat
Novartis Raises FullYear Guidance Signaling Strong Growth Prospects
Catalyst Bancorp Inc CLST Q3 2025 Earnings EPS of 013 Reported Stock Remains Flat
LOW Q1 2026 Earnings EPS Tops Estimates Amid Modest Revenue Headwinds
Thermon Group Holdings THR Q1 2026 Earnings A Narrow Miss on EPS Amid Modest Stock Gains
IDEX Corporation Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain
Prudential Financial PRU Q1 2026 Earnings Solid EPS Beat Amid Mixed Market Signals
CRGY Q1 2026 Earnings Strong EPS Beat Amid Energy Market Volatility
Howmet Aerospace HWM Slips 13 as Shares Test Key Support Levels
Power REIT PW Surges 15 to 071 Key Resistance at 075 in Play
Regal Rexnord RRX Tests Key Resistance as Shares Rally 224
Syntec Optics Holdings Warrant OPTXW Rallies 105 Key Resistance Test Ahead
Atea Pharmaceuticals AVIR Edges Higher Amid Renewed Investor Interest
Kiniksa Pharmaceuticals KNSA Slips 193 as Stock Tests 52 Level